Company Description
Niki BioSolutions, Inc., through its subsidiaries, operates as a clinical-stage biopharmaceutical company and engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases.
Its pipeline products include SACT-1, a repurposed drug candidate, which is in a Phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule, which is in a Phase 1 clinical trial for the treatment of bacterial infections, such as staphylococcus aureus, mycobacterium tuberculosis, and pseudomonas aeruginosa.
The company also develops SACT-COV19, a repurposed small molecule, which is in a preclinical trial for the treatment of coronavirus disease; SACT-2 and SACT-3; ALS-1, a small molecule, which is in a preclinical trial to treat bacterial infections caused by staphylococcus aureus, including methicillin-resistant staphylococcus aureus (MRSA); and ALS-2/3, a small molecule, which is in a preclinical trial for the treatment of gram+ve bacterial infections.
The company was formerly known as Aptorum Group Limited and changed its name to Niki BioSolutions, Inc. in July 2026.
Niki BioSolutions, Inc. was incorporated in 2010 and is headquartered in Princeton, New Jersey. Niki BioSolutions, Inc. operates as a subsidiary of Jurchen Investment Corporation.
| Country | United States |
| Founded | 2010 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1 |
| CEO | Chung Yuen Huen |
Contact Details
Address: 116 Village Boulevard, Suite 200 Princeton, New Jersey 08540 United States | |
| Phone | 609 951 2222 |
| Website | aptorumgroup.com |
Stock Details
| Ticker Symbol | NIKI |
| Exchange | NASDAQ |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001734005 |
| CUSIP Number | 653942102 |
| ISIN Number | US6539421023 |
Key Executives
| Name | Position |
|---|---|
| Chung Yuen Huen | Chief Executive Officer |
| Kwok Kuen Wong | Chief Financial Officer |